Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproheptadine for Appetite in Children
NCT07006181Completed
- Sponsor
- Universitas Indonesia
- Start
- Nov 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of cyproheptadine in anorexia nervosa (AN) and failure to thrive (FTT) (2 arms), sponsored by Universitas Indonesia. Primary endpoint: ECAST children's appetite scoring at 8 weeks. Started Nov 2024; status: completed.
02
Drugs
cyproheptadine
03
Conditions
anorexia nervosa (AN)failure to thrive (FTT)
Beyond the preview
Go deeper on NCT07006181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07006181.